Happiness Biotech Group Revenue 2019-2021 | HAPP

Happiness Biotech Group revenue from 2019 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Happiness Biotech Group Annual Revenue
(Millions of US $)
2021 $71
2020 $65
2019 $64
2018 $61
Happiness Biotech Group Quarterly Revenue
(Millions of US $)
2021-03-31
2020-09-30
2020-03-31
2019-09-30
2019-03-31
2018-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.028B $0.071B
Happiness Biotech Group Limited is a nutraceutical and dietary supplements producer. It is focused on the research, development, manufacturing and marketing of products made from Chinese herbal extracts and other ingredients. Happiness Biotech Group Limited is based in NANPING, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00